Literature DB >> 26719096

Human B cells have an active phagocytic capability and undergo immune activation upon phagocytosis of Mycobacterium tuberculosis.

Qi Zhu1, Min Zhang2, Ming Shi3, Yang Liu4, Qing Zhao3, Wenjing Wang3, Guangyun Zhang3, Longxiu Yang5, Jin Zhi6, Lin Zhang3, Gengyao Hu3, Pin Chen3, Yining Yang3, Wen Dai3, Tingting Liu3, Ying He3, Guodong Feng7, Gang Zhao8.   

Abstract

The paradigm that B cells are nonphagocytic was taken for granted for a long time until phagocytic B cells were found in early vertebrate animals. Thereafter, limited evidence has shown that human B cells may also internalize bacteria. However, whether human B cells can actively phagocytose bacteria has been less extensively investigated; in particular, the mechanisms and significance of the phagocytosis require clarification. Here, we show that the human Raji B cell line can phagocytose both live and dead Mycobacterium tuberculosis (Mtb), and the phagocytosed Mtb in turn affects the immune functions of the B cells. After incubation of Raji cells with Mtb, our confocal microscopy, electron microscopy and flow cytometry data showed that Raji cells effectively engulfed Mtb as well as latex beads. The phagocytic rate was proportional to the incubation time and the amount of Mtb or beads added. Additionally, we found that normal human serum could enhance the ability of Raji cells to phagocytose Mtb, while heat-inactivated serum reversed this promoting effect. The phagocytic process of B cells could partially be inhibited by cytochalasin B, an actin inhibitor. Importantly, the phagocytosed Mtb could regulate B cell immune functions, such as stimulating IgM production and upregulating the expression of the antigen-presenting costimulatory molecules CD80 and CD86. Therefore, our results provide the first evidence that human B cells can phagocytose Mtb in an active manner that is independent of bacterial viability, and phagocytosed Mtb can in turn regulate the immune activation of B cells.
Copyright © 2015 Elsevier GmbH. All rights reserved.

Entities:  

Keywords:  Human B cells; Immune response; Mycobacterium tuberculosis; Phagocytosis; Raji cells

Mesh:

Substances:

Year:  2015        PMID: 26719096     DOI: 10.1016/j.imbio.2015.12.003

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  15 in total

1.  CD4+ T-cell-independent mechanisms suppress reactivation of latent tuberculosis in a macaque model of HIV coinfection.

Authors:  Taylor W Foreman; Smriti Mehra; Denae N LoBato; Adel Malek; Xavier Alvarez; Nadia A Golden; Allison N Bucşan; Peter J Didier; Lara A Doyle-Meyers; Kasi E Russell-Lodrigue; Chad J Roy; James Blanchard; Marcelo J Kuroda; Andrew A Lackner; John Chan; Shabaana A Khader; William R Jacobs; Deepak Kaushal
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-06       Impact factor: 11.205

Review 2.  Understanding the Phagocytosis of Particles: the Key for Rational Design of Vaccines and Therapeutics.

Authors:  Silvia Moreno-Mendieta; Daniel Guillén; Nathaly Vasquez-Martínez; Rogelio Hernández-Pando; Sergio Sánchez; Romina Rodríguez-Sanoja
Journal:  Pharm Res       Date:  2022-06-23       Impact factor: 4.580

3.  Uptake of carbon nanodots into human AML cells in comparison to primary hematopoietic cells.

Authors:  Cathrin Nollmann; Christian Wimmenauer; Stefan Fasbender; Saskia Mayer; Ron-Patrick Caddedu; Paul Jäger; Thomas Heinzel; Rainer Haas
Journal:  RSC Adv       Date:  2021-08-02       Impact factor: 4.036

4.  Mycobacterium tuberculosis HN878 Infection Induces Human-Like B-Cell Follicles in Mice.

Authors:  José Alberto Choreño-Parra; Suhas Bobba; Javier Rangel-Moreno; Mushtaq Ahmed; Smriti Mehra; Bruce Rosa; John Martin; Makedonka Mitreva; Deepak Kaushal; Joaquín Zúñiga; Shabaana A Khader
Journal:  J Infect Dis       Date:  2020-04-27       Impact factor: 7.759

5.  Patients with Tuberculosis Have a Dysfunctional Circulating B-Cell Compartment, Which Normalizes following Successful Treatment.

Authors:  Simone A Joosten; Krista E van Meijgaarden; Franca Del Nonno; Andrea Baiocchini; Linda Petrone; Valentina Vanini; Hermelijn H Smits; Fabrizio Palmieri; Delia Goletti; Tom H M Ottenhoff
Journal:  PLoS Pathog       Date:  2016-06-15       Impact factor: 6.823

6.  B-cells with a FasL expressing regulatory phenotype are induced following successful anti-tuberculosis treatment.

Authors:  Ilana C van Rensburg; Léanie Kleynhans; Alana Keyser; Gerhard Walzl; Andre G Loxton
Journal:  Immun Inflamm Dis       Date:  2016-12-27

7.  Deregulated lncRNAs in B Cells from Patients with Active Tuberculosis.

Authors:  Yurong Fu; Xianqin Xu; Junfang Xue; Wenping Duan; Zhengjun Yi
Journal:  PLoS One       Date:  2017-01-26       Impact factor: 3.240

8.  Promising galactose-decorated biodegradable poloxamer 188-PLGA diblock copolymer nanoparticles of resibufogenin for enhancing liver cancer therapy.

Authors:  Hao Dong; Li Tian; Meng Gao; Hong Xu; Chenghong Zhang; Li Lv; Jianbin Zhang; Changyuan Wang; Yan Tian; Xiaochi Ma
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 9.  Quantifying intracellular Mycobacterium tuberculosis: An essential issue for in vitro assays.

Authors:  Deisy Carolina Rodriguez; Marisol Ocampo; Luz Mary Salazar; Manuel Alfonso Patarroyo
Journal:  Microbiologyopen       Date:  2018-02-27       Impact factor: 3.139

10.  IL-4-Responsive B Cells Are Detrimental During Chronic Tuberculosis Infection in Mice.

Authors:  Suraj P Parihar; Mumin Ozturk; Maxine A Höft; Julius E Chia; Reto Guler; Roanne Keeton; Ilana C van Rensburg; Andre G Loxton; Frank Brombacher
Journal:  Front Immunol       Date:  2021-06-15       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.